Ferroptosis Role in the Pathophysiology of Systemic Lupus Erythematosus
Recruiting
N/A
Interventional Study
Systemic Lupus Erythematosus
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Other
- Participants needed
- 120 (estimated)
- Sponsor
- University Hospital, Bordeaux · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The study aims at defining the role of ferroptosis s in the physiopathology of systemic lupus erythematosus (SLE). Ferroptosis (phenomenon of cellular death regulated by iron) is a metabolic pathway potentially implicated in SLE with potential for the discovery of new therapeutic strategies.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* age ≥ 18 years;
* diagnosis of systemic lupus erythematosus;
* being affiliated to health insurance, willing to participate and to sign informed consent;
* control group : patients with a diagnosis of rheumatoid arthritis or an inflammatory bowel disease.
Exclusion Criteria:
…
Contacts